Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy.
about
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanomaMultiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting.Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma.
P2860
Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Adjusting for treatment switch ...... ib compared with chemotherapy.
@en
type
label
Adjusting for treatment switch ...... ib compared with chemotherapy.
@en
prefLabel
Adjusting for treatment switch ...... ib compared with chemotherapy.
@en
P2093
P2860
P356
P1433
P1476
Adjusting for treatment switch ...... ib compared with chemotherapy.
@en
P2093
Helen Bell
Mayur M Amonkar
Michelle Casey
Nicholas R Latimer
P2860
P304
P356
10.1002/CAM4.643
P407
P577
2016-01-27T00:00:00Z